BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 30

• Press Releases

  Genome Editing Market Size to Reach USD 40.48 Billion by 2033

  June 21, 2024

   · 

  1 min read
• BioForest

  Pacific Northwest Research Institute Uncovers Hidden DNA Mechanisms of Rare Genetic Diseases

  Researchers at the Pacific Northwest Research Institute (PNRI) and collaborating institutions have made a groundbreaking discovery that could significantly advance our understanding of genomic disorders.

  June 21, 2024

   · 

  3 min read
• Drug Development

  Mozart Therapeutics Announces Oral Presentation on MTX-101 at the 2024 American Diabetes Association’s 84th Scientific Sessions

  Mozart Therapeutics, a clinical stage biopharmaceutical company focused on the development of CD8 Treg modulators for the treatment of autoimmune diseases, today presented new preclinical data on the Company’s lead program, MTX-101.

  June 21, 2024

   · 

  2 min read
• BioMidwest

  Common Cholesterol-Lowering Drug Found to Slow Vision Loss in Diabetes Patients

  Findings from the Lowering Events in Non-proliferative retinopathy in Scotland Trial revealed that fenofibrate, a medication used for many years to reduce blood fat levels, significantly reduces the progression of diabetic retinopathy, a diabetes-related eye disease.

  June 21, 2024

   · 

  4 min read
• Business

  On Path to First-in-Human Study, NurExone Engages Prominent Expert in Biological Drug Development

  NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company, welcomes Dr. Yona Geffen, as a consultant, to support the Company’s preclinical and clinical activities.

  June 21, 2024

   · 

  6 min read
• Business

  Palisade Bio Provides Update on Advancement of its Strategic Collaboration with Strand Life Sciences

  Palisade Bio, Inc. today provided an update on key areas of progress for its previously announced strategic collaboration with Strand Life Sciences (“Strand”), a leading bioinformatics specialist, aimed at advancing precision medicine for ulcerative colitis (UC) therapy.

  June 21, 2024

   · 

  4 min read
• BioHarvest Sciences Announces a Private Placement of up to USD $5 Million and Conversion of Debt Notes

  BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCD) (“BioHarvest” or the “Company”), announced today that its board of directors have approved a private placement of up to 697,350 units

  June 21, 2024

   · 

  3 min read
• Genetown

  Inozyme Pharma Announces Presentation and Sponsored Symposium at the 11th International Conference on Children’s Bone Health (ICCBH)

  Inozyme Pharma, Inc. announced a data presentation and sponsored symposium at the 11th International Conference on Children’s Bone Health, which is being held June 22-25, 2024, in Salzburg, Austria.

  June 21, 2024

   · 

  3 min read
• Deals

  Sharecare enters into definitive agreement to be acquired by Altaris

  Sharecare (Nasdaq: SHCR), the digital health company that helps people manage all their health in one place, announced today that it has entered into a definitive agreement to be acquired by an affiliate of Altaris, LLC, an investment firm exclusively focused on the healthcare industry.

  June 21, 2024

   · 

  11 min read
• Press Releases

  U.S. Multiomics Market Size to Reach USD 4.88 Billion by 2033

  June 21, 2024

   · 

  1 min read